Updated Jul 16, 2026
Krishnan Mahesh has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $548K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | HALO | HALOZYME THERAPEUTICS, INC. | S — Open-market sale | 7.3K | $75.00 | $548K |
| 2026-06-30 | HALO | HALOZYME THERAPEUTICS, INC. | M — Option exercise | 7.3K | $38.46 | $281K |
| 2026-05-07 | HALO | HALOZYME THERAPEUTICS, INC. | A — Grant or award | 3.8K | $0.00 | |
| 2025-05-01 | HALO | HALOZYME THERAPEUTICS, INC. | A — Grant or award | 4.2K | $0.00 |
Krishnan Mahesh is a corporate insider — currently tracked as Director of HALOZYME THERAPEUTICS, INC. (HALO). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($548K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Krishnan Mahesh profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.